May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Thil17 Plays a Role in Uveitis and Its Expansion Is Inhibited by Il-27
Author Affiliations & Notes
  • A. Amadi-Obi
    NEI/NIH, Bethesda, Maryland
    Lab. of Immunology,
  • C.-R. Yu
    NEI/NIH, Bethesda, Maryland
    Lab. of Immunology,
  • R. Mahdi
    NEI/NIH, Bethesda, Maryland
    Lab. of Immunology,
  • X. Liu
    NEI/NIH, Bethesda, Maryland
    Lab. of Immunology,
  • G. Clarke
    NEI/NIH, Bethesda, Maryland
    Clinical Immunology,
  • R. Nussenblatt
    NEI/NIH, Bethesda, Maryland
    Clinical Immunology,
  • I. Gery
    NEI/NIH, Bethesda, Maryland
    Lab. of Immunology,
  • C. Egwuagu
    NEI/NIH, Bethesda, Maryland
    Lab. of Immunology,
  • Footnotes
    Commercial Relationships A. Amadi-Obi, None; C. Yu, None; R. Mahdi, None; X. Liu, None; G. Clarke, None; R. Nussenblatt, None; I. Gery, None; C. Egwuagu, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1507. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Amadi-Obi, C.-R. Yu, R. Mahdi, X. Liu, G. Clarke, R. Nussenblatt, I. Gery, C. Egwuagu; Thil17 Plays a Role in Uveitis and Its Expansion Is Inhibited by Il-27. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1507. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: ThIL17 cells are implicated in pathogenesis of immune-mediated diseases. However, most of these studies have been in mice and involvement of ThIL17-cells in human diseases has not been firmly established. In this study, we show that ThIL17-cells may be involved in human uveitis or scleritis and have validated our findings in experimental autoimmune uveitis (EAU), a model of human uveitis.

Methods:: Human PBMC was isolated by density gradient centrifugation. PBMC or mouse CD4+ cells were cultured in medium containing various combinations of IL-2, IL-23, TGF-ß1/IL-6, anti-CD3/-CD28 Abs or IRBP. For induction of EAU mice were immunized with IRBP in CFA and disease was characterized by fundoscopy and histology. Expression of transcription factors, lymphocyte effector molecules and cytokine secretion were assessed by Western blotting, RT-PCR, qRT-PCR or ELISA. Phenotype of lymph node or ocular pathogenic T-cells was analyzed by FACS and intracellular staining.

Results:: The major findings in this study are the following: (i) A major difference between mice and "men" is that ThIL17 cells are detected in normal PBMC of humans but not mice: (ii) IL-17 is elevated in uveitis, scleritis and EAU and we show that its induction of TNFα expression in retinal cells may contribute to the pathology of chronic inflammatory disease of the eye; (iii) We further show that IL-27 is constitutively expressed in ganglion cell and inner plexiform layers of the retina and that expression of IL-27 in retinal cells is upregulated by IFNγ. (iv) IL-27 inhibits the proliferation of ThIL-17 uveitogenic T-cells.

Conclusions:: Taken together the data presented here suggest a novel mechanism by which Th1 cells may mitigate chronic inflammation by antagonizing ThIL17 phenotype through IFNγ-mediated STAT1-activation and induction of IL-27 in the target tissue. This first report that IL-2 promotes ThIL17-cells expansion provides explanations for efficacy of anti-IL2R therapy in uveitis and suggests that antagonism of ThIL17-cells by IFNγ/IL-27 maybe exploited in treating chronic inflammation.

Keywords: autoimmune disease • inflammation • uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×